ArticleNature communications2025
Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- IGLV3-21HemaSphere · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
A shared feature of B-cell receptors (BCRs) expressed on neoplastic B cells from patients with chronic lymphocytic leukaemia (CLL) concerns their continual activation of intracellular signalling without requiring external antigens. This autonomous signalling mechanism has previously been demonstrated to arise from BCR-BCR homotypic interactions in three distinct stereotyped CLL subsets (2, 4 and 169). CLL subset 1 is the second largest stereotyped subset, epitomizing unmutated CLL and known for a particularly aggressive clinical course. Here we show that, despite their significant sequence similarity, BCRs originating from three different subset 1 CLL cases exhibit variations in their combining site structures and associated physicochemical properties. Subset 1 BCRs are characterized by a common reactivity pattern towards various autoantigens, though they maintain distinct receptor-specific characteristics. Analysis of crystal structures of the respective BCR Fab fragments reveals lack of conservation in intermolecular crystal contacts, paralleled by no self-association in solution and incapacity to induce intracellular signalling when expressed in a model B-cell line. These findings suggest that cell-autonomous signalling may not be universally present across all CLL, implying the existence of other mechanisms in sustaining leukemic cell proliferation and CLL progression mediated by BCR signalling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.